Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,494,239
+$120,727 QoQ
Shares Held
9,821
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#2,163
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. JNJ ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,494,239 | 9,821 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,373,512 | 9,710 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,062,670 | 9,967 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,855,312 | 10,006 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,673,681 | 10,957 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,640,655 | 9,893 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,477,727 | 10,218 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,698,874 | 10,483 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,522,402 | 10,416 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,608,475 | 10,168 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,601,099 | 10,215 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $1,668,082 | 10,710 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $1,646,924 | 9,950 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $1,329,280 | 8,576 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $1,442,877 | 8,168 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $1,319,785 | 8,079 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $1,457,002 | 8,208 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $1,380,444 | 7,789 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $1,421,762 | 8,311 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $1,356,277 | 8,398 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $1,348,232 | 8,184 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $1,431,488 | 8,710 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $1,393,285 | 8,853 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $11,950 | 50,000 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $1,056,412 | 7,512 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $960,527 | 7,325 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||